Mikart Celebrates 50 Years of Excellence in Pharmaceutical Manufacturing
"This milestone is a testament to the hard work, dedication, and passion of our team over the past five decades," said
Throughout its history, Mikart has built a reputation for expertise in the development and manufacturing of tablets, capsules, and liquid products, becoming a trusted partner for pharmaceutical companies of all sizes. "We've worked tirelessly to ensure our clients receive not just products but solutions that address their unique challenges," Kallelis added. "This anniversary is as much about honoring our clients and their trust in us as it is about celebrating our achievements."
The company plans to commemorate this significant anniversary with a series of events and initiatives, and an employee celebration to honor the individuals who have been instrumental in Mikart's success.
"As we celebrate this golden anniversary, we're also looking to the future," said Kallelis. "We're investing in new technologies, expanding our capabilities, and reinforcing our commitment to sustainable practices. The next chapter for Mikart is about innovation, growth, and continuing to make a difference in the pharmaceutical industry."
For more information about Mikart's 50th anniversary or its services, visit www.mikart.com
About Mikart
Founded in 1975, Mikart is a leading CDMO specializing in the development and manufacturing of small-molecule pharmaceutical products. Based in
View original content to download multimedia:https://www.prnewswire.com/news-releases/mikart-celebrates-50-years-of-excellence-in-pharmaceutical-manufacturing-302353138.html
SOURCE Mikart, LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gargle Expands Dental SEO Strategy to Help Dental Practices Get Found in AI Search
- UNISORB Welcomes BILZ-USA to Expand Engineering and Product Solutions
- Hard Rock Hotel Malta Celebrates Star-Studded Grand Opening in St. George's Bay
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share